Thyroid Stimulating Hormone (TSH) ELISA
- Regulatory Status
- IVD
- Kit size
- 1 x 96
- Method
- ELISA
- Incubation time
- 1 x 60 / 1 x 20 min
- Standard range
- 0 - 25 μIU/mL
- Specimen / Volumes
- 100 µl serum
- Substrate / isotope
- TMB 450 nm
| instructions for use |
|---|
Intended Use
For the quantitative determination of thyroid stimulating hormone (TSH) concentration in human serum. The assay is useful in the diagnosis of thyroid or pituitary disorders.
Summary and Explanation
The determination of serum or plasma levels of thyroid stimulating hormone (TSH or thyrotropin) is recognized as a sensitive method in the diagnosis of primary and secondary hypothyroidism. [1] TSH is secreted by the anterior lobe of the pituitary gland and induces the production and release of thyroxine (T4) and triiodothyronine (T3) from the thyroid gland.[2] It is a glycoprotein with a molecular weight of approximately 28,000 Daltons, consisting of two chemically different subunits, alpha and beta.[3] Although the concentration of TSH in the blood is extremely low, it is essential for the maintenance of normal thyroid function. The release of TSH is regulated by a TSH-releasing hormone (TRH) produced by the hypothalamus. The levels of TSH and TRH are inversely related to the level of thyroid hormone. When there is a high level of thyroid hormone in the blood, less TRH is released by the hypothalamus, so less TSH is secreted by the pituitary. The opposite action will occur when there is decreased thyroid hormone in the blood. This process is known as a negative feedback mechanism and is responsible for maintaining the proper blood levels of these hormones. [4][5]
TSH and the pituitary glycoproteins: luteinizing hormone (LH), follicle-stimulating hormone (FSH), and human chorionic gonadotropin (hCG), have identical alpha chains [2]. The beta chains are distinct but do contain regions with identical amino acid sequences. These regions of homology can cause considerable cross-reactivity with some polyclonal TSH antisera. The use of a monoclonal antibody in this TSH ELISA test eliminates this interference, which could result in falsely elevated TSH values in either menopausal or pregnant females, a population whose evaluation of thyroid status is clinically significant [6][7][8].
For concrete data please consult the Instruction for Use in the download box on the top right side.
- Burger, H. G., Patel, Y. C., Thyrotropin releasing hormone-TSH Clinic. Endocrinol. and Metab., 6, 831-00(1977).
- Ezrin, C., The Thyroid, S. C. Werner and S. H. lngbar (eds.), Harper and Row, Hagerstown, MD, 9, 174-178 (1978).
- Pierce, J. G., Endocrinology, 89, 1331-1344 (1971).
- Berger, S. and Quinn, J. L., Fund. Clin. Chem., N. W. Tietz (ed.), W. B. Saunders Co., Phila., PA 14, 824-848 (1976).
- Utiger, R. D., The Thyroid, S.C. Werner and S. H. Ingbar (eds.), Harper and Row, Hagerstown, MD, 9, 196-205 (1978).
- Soos, M. and Siddle, K., J. Immun. Methods, 51, 57-68 (1982).
- Wada, H. G., Danisch, R. J., Baxter, S. R., et al, Clin. Chem.,28, 1862-1866 (1982).
- Snyder, P. J. & Utiger, R. D., J. Clin. Endo. Metab., 34, (1972).
Our Product Families
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
This is who we are.
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
Happy to help.
At Tecan, we are driven to improve people’s lives and health.